CoChat

Pathological Roles of Advanced Glycation End Product Receptors SR‐A and CD36

HORIUCHI, SEIKOH, UNNO, YUKA, USUI, HITOMI, SHIKATA, KENICHI, TAKAKI, KAORI, KOITO, WAKAKO, SAKAMOTO, YU‐ICHIRO, NAGAI, RYOJI, MAKINO, KENJI, SASAO, AKIRA, WADA, JUN, MAKINO, HIROFUMI · 2005 · Annals of the New York Academy of Sciences
Cited by 39

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

A bstract: The pathological significance of advanced glycation end product (AGE)‐modified proteins deposited in several lesions is generally accounted for by their cellular interaction via the AGE receptors and subsequent acceleration of the inflammatory process. In this study, we focused on two AGE receptors—specifically, the role of SR‐A in pathogenesis of diabetic nephropathy and the role of CD36 in AGE‐induced downregulation of leptin by adipocytes. In terms of SR‐A, diabetic wild‐type mice exhibited increased urinary albumin excretion, glomerular hypertrophy, and mesangial matrix expansion, whereas SR‐A‐knockout mice showed reduced glomerular size and mesangial matrix area. In these diabetic SR‐A‐knockout mice, the number of macrophages that infiltrated into glomeruli was remarkably reduced (P < 0.05), suggesting that SR‐A‐dependent glomerular migration of macrophages plays an important role in the pathogenesis of diabetic nephropathy. In terms of CD36, incubation of glycolaldehyde‐modified bovine serum albumin (GA‐BSA) with 3T3‐L1 adipocytes reduced leptin secretion by these cells. The binding of GA‐BSA to these cells and subsequent endocytic degradation were effectively inhibited by a neutralizing anti‐CD36 antibody. AGE‐induced downregulation of leptin was protected by N‐acetyl‐cysteine, an antioxidant. These results indicate that the interaction of AGE ligands with 3T3‐L1 adipocytes via CD36 induces oxidative stress and leads to inhibition of leptin expression by these cells, suggesting a potential link of this phenomenon to exacerbation of the insulin sensitivity in metabolic syndrome.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1196/annals.1333.076

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 39

Metadata

Authors
HORIUCHI, S., UNNO, Y., USUI, H., SHIKATA, K., TAKAKI, K., KOITO, W., SAKAMOTO, Y., NAGAI, R., MAKINO, K., SASAO, A., WADA, J., & MAKINO, H.
Venue
Annals of the New York Academy of Sciences
Publisher
Wiley
Published
2005-06
Volume
1043
Issue
1
Pages
671-675
ISSN
  • 0077-8923 (ISSN-L)
  • 1749-6632
OpenAlex
W2107307747
Cited by
39
References
2
FWCI
2.24
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pathological Roles of Advanced Glycation End Product Receptors SR‐A and CD36. https://app.cochat.ai/papers/10.1196/annals.1333.076
The paper
HORIUCHI, S., UNNO, Y., USUI, H., SHIKATA, K., TAKAKI, K., KOITO, W., SAKAMOTO, Y., NAGAI, R., MAKINO, K., SASAO, A., WADA, J., & MAKINO, H. (2005). Pathological Roles of Advanced Glycation End Product Receptors SR‐A and CD36. Annals of the New York Academy of Sciences. https://doi.org/10.1196/annals.1333.076

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.